PeptidePedia The community reference

ChinaPeptides: difference between revisions

Diff·revision 18 → 19·19:53, 25 Dec 2024

Difference between revision 18 and revision 19 of ChinaPeptides. 7 lines changed; the page grew by 1,145 bytes.

Revision 18 — 03:04, 21 Dec 2024
OrforglipronOona (talk)
label community tally as self-reported
4,096 bytes ±0
Revision 19 — 19:53, 25 Dec 2024
SiteReactionSuz (talk)
replace primary source with the review
5,241 bytes +1,145
1{{Infobox organisation1{{Infobox organisation
2| name = ChinaPeptides Co., Ltd. (QYAOBIO)2| name = ChinaPeptides Co., Ltd. (QYAOBIO)
+3| image = facility.svg
+4| caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki.
3| Legal name = ChinaPeptides Co., Ltd. (QYAOBIO)5| Legal name = ChinaPeptides Co., Ltd. (QYAOBIO)
4| Trading name = QYB6| Trading name = QYB
25The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.27The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.
2628
+29== Operations and documentation practice ==
+30Purchaser reports on custom orders describe a quotation stage, a stated lead time, and delivery with a certificate that in this set has usually included a mass-confirmation result alongside the purity figure.{{r|reports}} Mass confirmation by [[Mass spectrometry|mass spectrometry]] addresses a question that a purity figure does not — whether the material is the intended sequence at all — and its presence on a custom-synthesis certificate is the minimum a purchaser should expect.{{r|usp1503}}
+31
27== References ==32== References ==
28{{reflist}}33{{reflist}}
29<ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref>34<ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref>
30<ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref>35<ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref>
+36<ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref>
31<ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref>37<ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref>
+38<ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref>
32<ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref>39<ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref>
3340